Join the club for FREE to access the whole archive and other member benefits.

NuMedii

Disrupting Drug Discovery Using Big Data and Artificial Intelligence.

NuMedii discovers and de-risks effective new drugs by translating Life Sciences Big Data into therapies with a higher probability of therapeutic success. The Company’s proprietary and dynamic Big Data technology, developed in Atul Butte’s lab at Stanford University and licensed exclusively to NuMedii, consists of hundreds of millions of human, biological, pharmacological and clinical data points that the company has normalized and annotated. The company integrates these data with proprietary network-based algorithms to find both drug candidates and biomarkers predictive of efficacy for diseases.

Visit website: http://numedii.com/

 Numedii

 numedii

 NuMedii

Details last updated 07-Jul-2020

NuMedii News

9 Computational Drug Discovery Startups Using AI

Nanalyze - 25-Apr-2017

Including BenevolentAI which already has 24 drug candidates. 98% of big data has only been creat...

Read more...
Topics mentioned on this page:
Laboratory Automation, Artificial Intelligence (AI)